(Q42465007)

1 November 2017

title

Expression profiles of p63, p53, survivin, and hTERT in skin tumors (English)

1 reference

1 November 2017

Hye-Rim Park

1

1 reference

1 November 2017

Soo Kee Min

2

1 reference

1 November 2017

Hyun Deuk Cho

3

1 reference

1 November 2017

Kwang Ho Kim

4

1 reference

1 November 2017

Hyung Sik Shin

5

1 reference

1 November 2017

Young Euy Park

6

1 reference

1 November 2017

publication date

1 September 2004

1 reference

Journal of Cutaneous Pathology

1 November 2017

published in

1 reference

1 November 2017

volume

31

1 reference

1 November 2017

issue

8

1 reference

1 November 2017

page(s)

544-549

1 reference

p63 expression in normal skin and usual cutaneous carcinomas

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

p63 is a prostate basal cell marker and is required for prostate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Expression of the p53 homologue p63 in early cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

P63 and P73: P53 mimics, menaces and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

p63 expression in normal human epidermis and epidermal appendages and their tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

p63 is a p53 homologue required for limb and epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Differential expression of p63 isoforms in normal tissues and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

From actinic keratosis to squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Frequent clones of p53-mutated keratinocytes in normal human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

Immunohistochemical detection of p53 tumor suppressor protein in porokeratosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0303-6987.2004.00228.X

10.1111/J.0303-6987.2004.00228.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference